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Purpose: Skeletal muscle ischaemia reperfusion syndrome affects patients following lower limb revascularisation. Aspirin 
has the potential to attenuate these ffects. 
Methods: Using an established model of hind limb tourniquet ischaemia, the effects of oral and intravenous aspirin 
administration were observed after 6 h of ischaemia and 18 h reperfusion. Samples were obtained and analysed for muscle 
viability and oedema, nd lung neutrophil infiltration. 
Results: Aspirin, when compared to placebo and controls, significantly increased muscle interstitial oedema when given 
orally and intravenously. It had no effect on tissue viability or lung neutrophil infiltration. 
Conclusion: Aspirin increases tissue oedema after ischaemia and reperfusion but has no effect on tissue viability. Although 
its mechanism ofaction has not been clarified, aspirin may influence the no-reflow component of ischaemia-repeffusion 
syndrome. 
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Introduction 
The introduction of oxygenated blood to ischaemic 
skeletal muscle can lead, paradoxically, to an increase 
in tissue injury. This is termed the ischaemia-reperfu- 
sion syndrome and is thought o be caused, in part, by 
free radical-mediated activation of lipid peroxidation. 
The products of this cellular damage initiate a cascade 
of injury involving thromboxane, polymorphonuclear 
cells, cytokines and endothelial adhesion molecules. 
Tissue damage can occur locally or at distant sites. In 
the lung the injury manifests as neutrophil sequestra- 
tion and non-cardiogenic pulmonary oedema. Current 
research is directed at methods to ameliorate or 
prevent he reperfusion i jury. 1 
There is evidence to suggest that free radicals may 
be involved in local and distant organ damage during 
peripheral thrombolysis. 2"3 Aspirin has recently been 
shown to improve the results of peripheral arterial 
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thrombolysis with tissue plasminogen activator, 
(t-PA). 4 The mechanism ofaction of aspirin in patients 
receiving t-PA thrombolysis may be through inhibi- 
tion of platelet activity or by reducing neutrophil 
activation secondary to a reduction in thromboxane 
production. Thromboxane acts as a potent chemoat- 
tractant in the inflammatory process. 5-7 
A rodent model of acute lower limb ischaemia, 
using a rubber band tourniquet is simple but repro- 
ducible and is frequently used to study ischaemia- 
reperfusion i jury. 8 The aim of the study was to use 
this model to evaluate the potential of aspirin to 
ameliorate the local and distant effects of skeletal 
muscle ischaemia-reperfusion. 
Materials and Methods 
Thirty-four male Sprauge-Dawley rats weighing 
300-450g were divided into four groups. Group one 
received oral aspirin (n= 10), Group two (placebo, 
n=8) received water, group three received intra- 
venous aspirin (n = 8) and group four acted as controls 
(n = 8). 
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Groups 1 and 2 (oral aspirin and Placebo) 
On four consecutive days, aspirin (5mg/ml) was 
given by orogastric intubation to group 1 (5mg/kg) 
and lml of water was given, in similar fashion, to the 
placebo group. This dose was chosen as it is equiva- 
lent to a single daily dose of 300mg aspirin in an adult 
human. On the fourth day the animals were anaes- 
thetised by intraperitoneal acepromazine maleate 
(10mg/ml) and Ketamine HCL (5mg/ml), allowing 
spontaneous respiration. The right jugular vein was 
cannulated under direct vision by a 24G catheter. An 
intravenous (i.v.) infusion of 0.9% Saline (Normal/ 
saline), (3ml/kg/h) was started and continued 
throughout the experiment. An elastic band was 
placed around the right upper thigh of the animal to 
produce ischaemia. Interruption of arterial flow was 
confirmed by loss of the posterior tibial artery doppler 
signal using a hand held doppler with a 4MHz probe 
(Dopplex, Huntleigh Healthcare, Cardiff, U.K.). 
Anaesthesia was maintained throughout he experi- 
ment by intermittent boluses of intraperitoneal naes- 
thetic titrated to depth of anaesthesia, heart rate, 
corneal reflex and non-ischaemic toe pinch response. 
After 6 h the tourniquet was removed and restora- 
tion of distal blood flow confirmed by doppler 
examination. The jugular venous line was removed, 
with ligation of the vessel and the wound closed. The 
animals were then allowed to recover from 
anaesthesia. 
After 18 h of reperfusion, the animals were anaes- 
thetised. The anterior tibial muscles of both lower 
limbs were dissected out and immediately processed 
for staining and reducing capacity (see analysis of 
samples). After sacrifice of the animals, the left lung 
was removed, partially inflated with a solution of 
formaldehyde and preserved in 10% aqueous formalin 
for later analysis. The gastrocnemius muscle of both 
limbs was removed, weighed and placed in a dessica- 
tor prior to analysis of wet/dry weight ratio. 
Group 3 (i.v. aspirin) 
These animals were anaesthetised and one hind limb 
rendered ischaemic as before. After 5 h of ischaemia, 
the i.v. infusion of Normal/saline was exchanged for 
one containing a sterile solution of aspirin (N-Ace- 
tylsalicylic acid; Crystalline form, Sigma) at a concen- 
tration of 2.5mg/ml of Normal/saline at 37°C. The 
infusion was given over half an hour to achieve a dose 
of 5mg/kg for each animal. Once the infusion had 
been completed, the Normal/saline was continued 
and after 6 h of ischaemia the tourniquet was released. 
Sampling and further treatment was identical to 
groups one and two. 
Group 4 (control) 
These animals were treated in an identical fashion to 
group 3 except he hind limb was not made ischaemic, 
aspirin was not given and the Normal/saline infusion 
was continued throughout the experiment. 
All animal care complied with the Principles of 
Laboratory Animal Care and the Guide for the Care 
and Use of Laboratory Animals (NIH Publication 
80-23, revised 1985). Approval of the experimental 
protocol was given by the University of California, 
Los Angeles, Chancellor's Animal Research 
Committee. 
Analysis of samples 
All measurements were performed by an investigator 
blinded to the treatment groups. 
Anterior tibial muscle (muscle cell viability) 
The anterior tibial muscle samples were sectioned 
immediately after harvesting, perpendicular to their 
long axis, in such a way as to provide one small 
proximal sample (1/3) and one large distal sample 
(2/3). 
Frozen section 
For each limb, the smaller of the two samples was 
snap-frozen in a solution of Methyl-Butane and dry 
ice, with the cut surface against a microtome block. 
Frozen sections from different levels of the muscle 
were prepared, fixed in formal-alcohol and then 
stained for 15 min with Nitro Blue Tetrazolium (NBT) 
using a solution of 20mg NADP (Sigma), 6ml Phos- 
phate buffer ~pH 7.4, 4ml distilled water and 10mg 
NBT (Sigma)Z Fresh solution was prepared with each 
batch staining. Using computerized morphomertic 
analysis (Microscale TH/TC Image Analysis: Dig- 
ithurst; Olympus BH-2 microscope and JVC colour 
close circuit camera), transverse muscle sections were 
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viewed by light microscopy at magnification of × 100 
to determine the percentage of the slide occupied by 
fibres showing blue reactivity (viable tissue) or 
absence of stain (non-viable tissue). All fibres in each 
field were examined (Median 100 fibres, range 
85-126). The ratio of ischaemic muscle to viable 
muscle was then calculated. 1°
Triphenyltetrazolium chloride (TTC) and protein assays 
The larger anterior tibial sample was immediately 
weighed, cut into small sections and then added to 
3ml of 0.25 M sucrose solution before being homoge- 
nised for 90s. Additional 0.25 M sucrose solution was 
added to make a 20% by weight homogenate. This 
was strained through fine wire mesh. A Coomassie 
blue protein assay was performed on 0.1ml of the 
homogenate with infrared spectroscopic analysis at 
595nm. 11 One millilitre of homogenate was added to 
lml of 0.15% TTC buffered solution and incubated at 
39°C in an agitating water bath for 30min before the 
reaction was stopped by adding 4ml acetone. The 
solution was mixed well, then centrifuged for 10 min 
at 1500rpm (equivalent to 1000g). The absorbance of 
the supernatant was measured at 485nm and sub- 
tracted from the reagent blank to obtain a corrected 
final value. The values for protein and the amount of 
TTC reduced were calculated by comparing absor- 
bance values to a standard calibration curve of known 
protein and TTC concentrations. The amount of TTC 
reduced per hour per milligram of protein was 
calculated by dividing TTC reduced (/zg/h) by the 
concentration of protein (mg/ml) in each sample. ~2 
Gastrocnemius muscle (wet~dry ratio) 
Gastrocnemius muscle samples and their containers 
were placed in a desiccating incubator (40°C, 20% 
humidity) and weighed every other day until there 
was no reduction in three consecutive measurements. 
The wet weight was divided by the final weight (dry 
weight) to give a wet/dry ratio for each muscle. 
Lungs (neutrophil count) 
A standard method was used to determine neutrophil 
inflammatory activity in the lung. 13'14 Sections of 
formalin-fixed, paraffin embedded, 4Fro thick, lung 
tissue were stained with haematoxylin and eosin, and 
viewed using light microscopy to identify areas of 
alveolar distension. Under high power ( × 1000 with 
oil immersion microscopy), the number of poly- 
morphonuclar cells within each alveolar wall and 
space was determined by an experienced pathologist. 
This process was repeated in multiple fields of the 
same lung and an average of six fields were counted. 
Counts were not taken close to bronchi, lymph nodes 
or major vessels, nor in areas where the lung infla- 
tion/distension appeared sub-optimal. 
Statistical Analysis was performed by a Mann- 
Whitney U-test with significance if p < 0.05. 
Results 
Muscle viability 
Aspirin did not affect muscle viability after ischaemia 
and reperfusion. The median value for the Nitro-blue 
tetrazolium staining ratio in the placebo group was 0.5 
(range (r) 0.1-0.9), which was not significantly differ- 
ent from that for oral (0.3, r 0.1-1.0) or intravenous 
aspirin (0.5, r 0.1-0.9). The median ratio for the control 
group was 1.0 (r 0.5-1.9). 
The median value for reduction of triphenylte- 
trazolium chloride by ischaemic muscle from the 
placebo animals was 1.3 mg/h (range 1.2-1.5), for oral 
aspirin 1.4 mg/h (range 1.2-1.8), for i.v. aspirin 1.3 
mg/h  (range 1.2-1.4) and controls 1.6 mg/h  (range 
1.3-1.8), (Fig. 1). There was no significant difference 
between the values of the three treatment groups 
(p = 0.38-0.43), but all were significantly different from 
the control group (p < 0.01). 
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Fig. 1. Scatterplot showing the distribution of Triphenyltetrazolium 
chloride reduction by muscle subjected to 6 h of ischaemia nd 18 h 
reperfusion. 
Eur J Vasc Endovasc Surg Vol 12, July 1996 
Aspirin and Ischaemia Reperfusion 79 
2 
~9 
N 
N 
,Ik V 
Control Placebo 
• 
O0 
• i | 
I I 
Oral Intravenous 
Fig. 2. Scatterplot showing the distribution ofwet/dry weight ratios 
of muscle subjected to ischaemia nd reperfusion. 
Muscle oedema 
Aspirin, in both oral and intravenous forms, was 
associated with an increase in skeletal muscle oedema. 
The median wet/dry ratio of ischaemic limbs in the 
placebo animals was 3.69 (range 3.44-3.97), oral 
aspirin group 4.73 (range 3.62-6.45), i.v. aspirin group: 
4.63 (range 3.77-6.0) and controls 3.38 (range 
3.22-3.58) (Fig. 2). There was a significant difference 
between placebo and oral groups and placebo and i.v. 
groups (p<0.01) while all treatment group values 
were significantly different from the control group 
(p < 0.01). There was no significant differences in the 
ratios of the non ischaemic muscles. 
Lung neutrophil nfiltration 
The median number of neutrophils in each micro- 
scopic field was 12 in all three treatment groups and 
the range was also similar (6-21). For the control 
group the median number was lower (9, range of 
6-17). There was no statistical difference between 
control and treatment groups, although there was a 
trend towards significance, (p = 0.06). 
Discussion 
The rodent model of hind limb ischaemia is well 
established in the investigation of skeletal muscle 
ischaemia-reperfusion syndrome, s Although rubber 
band limb ligation is a crude method for producing 
ischaemia, it has been shown that arterial blood flow is 
reduced by 98%. 15 This model of sub maximal 
r~d~ction i  arterial inflow may more truly reflect he 
state of a human patient who presents with an acute 
arterial occlusion than other animal models in which 
the hind limb is amputated save for the main vascular 
supply. 16 One disadvantage of the technique is that 
venous oedema can follow. In the present series of 
experiments, sampling was delayed for 18 h to 
minimise this effect and allow the reperfusion phase 
to become stablished. 17
For an agent to be effective in ameliorating ischae- 
mia-reperfusion i jury, it needs to be active in the first 
30-90 min after reperfusion. Aspirin given prior to, or 
during ischaemia was in the circulation at the time of 
reperfusion but had no effect on muscle viability and 
paradoxically increased tissue oedema. Failure to 
improve muscle viability may reflect a lack of influ- 
ence of aspirin on the processes involved within the 
tissues. Alternatively, the amount of tissue damage 
after 6 h tourniquet ischaemia nd 18 h reperfusion 
may be so severe that the muscle is beyond the 
therapeutic window for aspirin to be effective, is Other 
agents used in this model have been effective after 6 h 
of ischaemia but reperfusion was usually monitored 
for 4 h. 15 This relatively short duration of reperfusion 
may have been insufficient for the effects of the 
reperfusion cascade to become stablished. It has been 
suggested that 18 h is the optimum time to evaluate 
the effects of reperfusion. ~7 It is possible that measur- 
ing viability at 4 h of reperfusion might have shown a 
beneficial effect of aspirin but in the context of 
therapeutic benefit, a longer duration of reperfusion 
would appear to be more relevant. 
The increased tissue oedema after oral aspirin 
administration might be explained by a reduction in 
the no-reflow phenomenon. 6 Ischaemia nd reperfu- 
sion result in an inflammatory response including 
increased vascular permeabilit)~ neutrophil-endothe- 
lial adhesion and platelet activation with thrombus 
formation within capillaries. Pre-dosing with oral 
aspirin could have altered platelet function, prevent- 
ing or reducing intravascular thrombosis, so increas- 
ing hydrostatic pressure and creating more oedema t 
the time of reperfusion. 19Intravascular thrombosis is 
not thought o be a major component in the reperfu- 
sion cascade so the observed increase in oedema could 
be an effect of aspirin while the lack of preservation of
muscle viability suggests that it is of little use in this 
condition. Alternatively, the observed effect of aspirin 
may have been related to the model of ischaemia used. 
Nonsteroidal anti-inflammatory drugs can increase 
inflammation in rodent models during mast cell- 
dependent inflammation. 2°The observed increase in 
tissue oedema in this study may therefore have 
occurred in similar fashion. Investigation of muscle 
oedema in humans might show a different response. 
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Lung injury following skeletal muscle reperfusion 
has been shown in other models and the reduced 
counts in the control group would support these 
observations) 3'2~ Aspirin does not appear to have an 
effect on this injury which is thought o be mediated 
by neutrophils, even though thromboxane may have 
an important role. 22 
The ischaemia-reperfusion syndrome is complex 
and any therapy needs to be directed at more than one 
event in the cascade. 23 Aspirin gives little or no benefit 
in the attenuation of this injury but the observation of 
increased tissue oedema requires further 
investigation. 
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